daisy miller created a new article
15 hrs

Rucaparib: A Breakthrough in Targeted Cancer Therapy | #rucaparib manufacturers

Rucaparib: A Breakthrough in Targeted Cancer Therapy

Rucaparib: A Breakthrough in Targeted Cancer Therapy

Rucaparib was initially approved for use in patients with advanced ovarian cancer who have been treated with two or more prior lines of chemotherapy and have a confirmed BRCA mutation.